Cano Health (CANO) reported Q4 EPS of ($0.61), $0.49 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $680.37 million versus the consensus estimate of $651.64 million.
GUIDANCE:
Cano Health sees FY2023 revenue of $3.1-3.25 billion, versus the consensus of $3.26 billion.